Click on the title to download the press clipping:

ECHOUTCOME: Challenging QALYs, BioCentury Week in Review – September 2, 2013
courtesy of Ms. Susan Schaeffer, BioCentury – The Bernstein Report on BioBusiness Editor

Report triggers quibbles over QALYs, a staple of health metrics – Nature Medicine – Volume 19 – March 2013
ABPI comments about Echoutcome – ABPI – 25/01/2013
Flaws in the QALY show why we need a broader definition of value – ABPI – 25/01/2013
Researchers claim NHS drug decisions ‘are flawed‘ – BBC News – 24/01/2013
Is the NHS using a ‘flawed’ method to decide which drugs are best? – British Journal of Healthcare computing – 28/01/2013
Drug watchdog should scap ‘flawed’ system used to ration life-saving medicines, warn EU experts – MailOnLine – 26/01/2013
Drug-approval formula ‘flawed’ – – 25/01/2013
QALY is not valid for quality decisionmaking? – Pharmalot – 28/01/2013
Calls for abolition of QALY, Sir Bruce attack opponents of hospital closures and CMO warns of drug-resistant bacteria epidemic – Pulse – 26/01/2013
Nice’s drug-approval formula is flawed, warn researchers – The Independent – 26/01/2013
System used to decide whether drugs are cost-effective for NHS ‘is flawed ‘ – The Telegraph

Project description on Cordis website

Echoutcome kick-off meeting – Press release

The European Consortium in Healthcare Outcomes and Cost-Benefit research (ECHOUTCOME) is initiating in March 2010 a new European project in the frame of the Seventh Framework Programme of the European commission.

For the first time, this innovative project will compare the health system organizations of the 27 Member States and will study the robustness of health outcomes currently used by health technology assessment authorities in Europe.

The scientific validity of synthetic indicators such as the Quality Adjusted Life Years (QALY), the Disability Adjusted Life Years (DALY) or Healthy Years Equivalent (HYE) will be extensively investigated and recommendations will be proposed to Member States at the end of the project in 2013.
The consortium is composed by experts from Data Mining International (Switzerland), the University of Bocconi (Italy), the Université Libre de Bruxelles (Belgium), the French Society of Health Economics (SFES), Cyklad Group (France), Lyon Ingénierie Projets and the Claude Bernard University (France), which coordinates the project.

Press contact : press(at)